Clinical study on individualized diagnosis and treatment of sepsis-associated liver injury

Clinical study on individualized diagnosis and treatment of sepsis liver injury

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045365

Enrollment

Unknown

Registered

2021-04-13

Start date

2021-05-01

Completion date

Unknown

Last updated

2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis-associated liver injury

Interventions

sepsis group vs. healthy control group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=18 years; 2.Meet the 2016 international sepsis diagnostic criteria; 3.Patients with liver injury, with transaminase>2 times the normal value and/or total bilirubin (TBIL)>=34 umol/L; 4.Sign informed consent.

Exclusion criteria

Exclusion criteria: Active or progressive underlying liver disease, autoimmune or neoplastic disease.

Design outcomes

Primary

Measure	Time frame
CARD9 gene locus;	—

Countries

China

Contacts

Public ContactWang Xuemin

Shanghai Songjiang District Central Hospital

602336033@qq.com+86 18918285282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026